Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Stem cells: the blue print for the future.

¹Advanced Centre for Biochemical Engineering, University College London, UK. chris.mason@ucl.ac.uk

Medical Device Technology

|June 2, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Applied Astrobiology: An Integrated Approach to the Future of Life in Space.

Astrobiology·2025

Same author

Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations.

Molecular therapy : the journal of the American Society of Gene Therapy·2024

Same author

An autonucleolytic suspension HEK293F host cell line for high-titer serum-free AAV5 and AAV9 production with reduced levels of DNA impurity.

Molecular therapy. Methods & clinical development·2024

Same author

Trimethoprim-sulfamethoxazole acute respiratory distress syndrome requiring lung transplantation.

Respirology case reports·2024

Same author

Engineering an Autonucleolytic Mammalian Suspension Host Cell Line to Reduce DNA Impurity Levels in Serum-Free Lentiviral Process Streams.

ACS synthetic biology·2024

Same author

Serum-free lentiviral vector production is compatible with medium-resident nuclease activity arising from adherent HEK293T host cells engineered with a nuclease-encoding transgene.

Heliyon·2023

Same journal

Safer arterial access.

Medical device technology·2010

Same journal

Building better surfaces.

Medical device technology·2010

Same journal

PVC: a broader perspective.

Medical device technology·2010

Same journal

Joining and forming using torsional ultrasonic principles.

Medical device technology·2010

Same journal

US regulation of combination products.

Medical device technology·2010

Same journal

Assessing biological safety of metals associated with medical devices.

Medical device technology·2010

See all related articles

Significant investment fuels stem-cell therapies and technologies, aiming for on-demand tissue generation within two decades. This field promises substantial rewards, with a projected market value of $500 billion annually.

Area of Science:

Regenerative Medicine
Biotechnology
Tissue Engineering

Background:

Substantial investment is being directed towards stem-cell therapies and technologies.
The field aims for ambitious goals, such as generating tissues on demand within 20 years.
The potential market for these advancements is estimated at a significant US dollar 500 billion annually.

Purpose of the Study:

To outline current stem-cell research and development activities.
To provide an overview of progress on both sides of the Atlantic.

Main Methods:

Review of current stem-cell research initiatives.
Analysis of investment trends in regenerative medicine.
Comparative overview of activities across North America and Europe.

Related Experiment Videos

Main Results:

Impressive investment is flowing into stem-cell therapies and technologies.
Clear objectives are set, including the 20-year goal for tissue generation.
The potential market size is substantial, estimated at US dollar 500 billion per year.

Conclusions:

The field of stem-cell therapy is experiencing significant growth and investment.
The ambitious goals set for tissue engineering are driving innovation.
The transatlantic landscape of stem-cell research is active and evolving.